Clinical Trial Update: Efficacy and Safety/Tolerability of Ragweed MATA MPL [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety/tolerability of Ragweed MATA MPL for Type I hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Hypersensitivity

Drugs mentioned

• Ragweed MATA MPL

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 3 | Status: COMPLETED